134 results
Page 5 of 7
20-F/A
m1o9v9j5rx0o6u
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.39
hqnj8250ljdanp0 5g07
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
EX-4.17
laxd994n 94k
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
vemsbavsl5ms19l3
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
ls0zvjx 77te
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
lz8qjvdurmn
5 Mar 15
Current report (foreign)
12:00am
424B2
nz7hst72ck14s
13 Jun 14
Prospectus for primary offering
12:00am
6-K
EX-1.1
cj3co5y yso
30 May 14
Current report (foreign)
12:00am
F-3
stkok8t
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-1.1
odh7uyuhk 7psm3
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B5
iv9byz3hk7
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
aodx088zk9b6pjjk8a
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
34b2wjtu
3 Mar 14
Current report (foreign)
12:00am
424B3
f6z5fmbmzzld8z 1k
8 Aug 13
Prospectus supplement
12:00am
424B5
hzrtzib4ldw4f dwdtb
17 May 13
Prospectus supplement for primary offering
12:00am